STOCK TITAN

Quantum-Si Incorporated - QSI STOCK NEWS

Welcome to our dedicated page for Quantum-Si Incorporated news (Ticker: QSI), a resource for investors and traders seeking the latest updates and insights on Quantum-Si Incorporated stock.

Quantum-Si Incorporated (symbol: QSI) is revolutionizing the field of proteomics with cutting-edge technologies. The company has developed a unique semiconductor chip that enables single-molecule, next-generation protein sequencing and genomics, going beyond traditional DNA sequencing. This innovation is set to digitize proteomic research, significantly advancing drug discovery and diagnostics.

Founded by successful entrepreneurs and fully funded to focus on groundbreaking science, Quantum-Si fosters an environment where highly committed individuals are encouraged to solve tough problems and create impactful technologies. The company is headquartered in Guilford, Connecticut, and continues to attract bright minds dedicated to transforming healthcare.

Quantum-Si's core products include a suite of technologies that leverage their proprietary semiconductor chip for high-precision protein analysis. These products are designed to provide deeper insights into the proteome, which is essential for understanding diseases, developing new therapies, and personalizing medicine.

Recent achievements highlight Quantum-Si's commitment to innovation and excellence. The company has formed strategic partnerships with leading research institutions and pharmaceutical companies to accelerate the adoption of its technologies. Additionally, Quantum-Si continues to invest in research and development to enhance its product offerings and expand its market reach.

Financially, Quantum-Si is backed by substantial funding from its founders, allowing the company to prioritize innovation and market entry without the immediate pressures of profitability. This financial stability ensures that the company can focus on long-term goals and sustainable growth.

For those interested in joining a dynamic and innovative team, Quantum-Si offers a range of career opportunities. Visit their job postings at 4Catalyzer to learn more about current openings.

Empower discovery. Empower health. Empower you.

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced a distribution agreement with Elta 90 to distribute its Platinum™ instrument and consumables in Southeast Europe. This partnership aims to meet the growing demand for next-generation protein sequencing™ platform, which offers single-molecule amino acid resolution. The agreement is expected to accelerate scientific research and expand the field of proteomics, making the technology more accessible to scientists in every lab, everywhere.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
none
-
Rhea-AI Summary
Quantum-Si (Nasdaq: QSI) announced financial results for Q3 2023, recording revenue of $223,000 and gross profit of $108,000. The Company completed a strategic review of R&D programs and organizational design, presented first customer data, and added an independent director to the Board. The Company expects full year 2023 adjusted total operating expenses to be approximately $100 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.77%
Tags
-
Rhea-AI Summary
Quantum-Si Inc. (Nasdaq: QSI) has been awarded 'Proteomics Company of the Year' by the BioTech Breakthrough Awards for its groundbreaking Platinum™ protein sequencing instrument. The award recognizes Quantum-Si's pioneering focus on proteomics and the exceptional caliber of its team. This accolade highlights the immense progress made in the proteomics industry in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.06%
Tags
none
Rhea-AI Summary
Quantum-Si (Nasdaq: QSI) will be participating in two investor conferences: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Evercore ISI HealthCONx Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
conferences
-
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) will showcase its next-generation benchtop protein sequencing instrument, Platinum, at the American Society of Human Genetics conference. Platinum is a groundbreaking advancement in protein sequencing, enabling precise, single-molecule resolution. Quantum-Si aims to transform genomics and proteomics research with this tool.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
-
Rhea-AI Summary
Quantum-Si to report Q3 2023 financial results and host conference call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
conferences earnings
Rhea-AI Summary
Quantum-Si to hold webinar on their novel next-generation protein sequencing platform
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
none
-
Rhea-AI Summary
Quantum-Si to hold webinar on advances in protein identification and characterization
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
none
-
Rhea-AI Summary
Quantum-Si to present at the Festival of Genomics & Biodata, showcasing their next-generation Protein Sequencing technology. Platinum, their single-molecule protein sequencing platform, aims to accelerate breakthroughs in proteomics research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
conferences
Rhea-AI Summary
Quantum-Si appoints Amir Jafri to its Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
management

FAQ

What is the current stock price of Quantum-Si Incorporated (QSI)?

The current stock price of Quantum-Si Incorporated (QSI) is $1.96 as of January 30, 2025.

What is the market cap of Quantum-Si Incorporated (QSI)?

The market cap of Quantum-Si Incorporated (QSI) is approximately 318.3M.

What does Quantum-Si Incorporated do?

Quantum-Si specializes in proteomics, using semiconductor technology for next-generation protein sequencing and genomics.

What is the significance of Quantum-Si's semiconductor chip?

The chip enables single-molecule protein sequencing, advancing drug discovery and diagnostics beyond traditional DNA sequencing.

Where is Quantum-Si headquartered?

Quantum-Si is headquartered in Guilford, Connecticut.

Who funds Quantum-Si?

The company is fully funded by its successful founders.

What are Quantum-Si's core products?

Their core products include technologies that use their proprietary semiconductor chip for high-precision protein analysis.

What recent achievements has Quantum-Si made?

Recent achievements include strategic partnerships with leading research institutions and continued investment in R&D.

What opportunities are available at Quantum-Si?

Quantum-Si offers various career opportunities. Visit their job postings at 4Catalyzer for more details.

How does Quantum-Si contribute to healthcare?

Quantum-Si's technologies provide deeper insights into the proteome, essential for understanding diseases and developing new therapies.

What is the financial condition of Quantum-Si?

Quantum-Si is financially stable, backed by substantial funding from its founders, allowing focus on long-term growth.

How can I stay updated with the latest news about Quantum-Si?

You can stay updated with the latest news on Quantum-Si by visiting their section on StockTitan or their official website.
Quantum-Si Incorporated

Nasdaq:QSI

QSI Rankings

QSI Stock Data

318.26M
101.45M
12.9%
27.29%
11.74%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BRANFORD